Australian Pancreatic Cancer Genome Initiative (APGI)

Australia

1 August 2018 - 31 July 2019

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for Australian Pancreatic Cancer Genome Initiative (APGI) published between 1 August 2018 - 31 July 2019 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Research collaboration: Australian Pancreatic Cancer Genome Initiative (APGI) is a research collaboration whose article contributions are accrued to its participating partner institutions.

Note: Articles may be assigned to more than one subject area.

AC FC
1 0.22

Outputs by subject (FC)

Subject AC FC
Life Sciences 1 0.22

Top articles by Altmetric score in current window

Article has an altmetric score of 22

ROBO2 is a stroma suppressor gene in the pancreas and acts via TGF-β signalling

Nature Communications

2018-11-30

1 August 2018 - 31 July 2019

International vs. domestic collaboration by FC

  • 56.2% Domestic
  • 43.8% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by FC (6 total)

  • Australian Pancreatic Cancer Genome Initiative (APGI), Australia
  • Domestic institution
  1. Garvan Institute of Medical Research, Australia (0.52)
    0.22
    0.30
  2. University of New South Wales (UNSW), Australia (0.34)
    0.22
    0.12
  3. Lowy Cancer Research Centre, Australia (0.28)
    0.22
    0.05
  4. Children's Cancer Institute Australia (CCIA), Australia (0.25)
    0.22
    0.03
  5. Macquarie University, Australia (0.24)
    0.22
    0.02
  6. The University of Sydney (USYD), Australia (0.24)
    0.22
    0.02

Top 10 international collaborators by FC (5 total)

  • Australian Pancreatic Cancer Genome Initiative (APGI), Australia
  • Foreign institution
  1. Free University of Brussels (VUB), Belgium (0.46)
    0.22
    0.24
  2. Peking University (PKU), China (0.26)
    0.22
    0.04
  3. Johns Hopkins Health System Corporation (JHHS), United States of America (USA) (0.25)
    0.22
    0.03
  4. Johns Hopkins University (JHU), United States of America (USA) (0.25)
    0.22
    0.03
  5. NHS Greater Glasgow and Clyde (NHSGGC), United Kingdom (UK) (0.24)
    0.22
    0.01

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Australian Pancreatic Cancer Genome Initiative (APGI)

Participating institutions

Australian Pancreatic Cancer Genome Initiative (APGI) is a research collaboration whose article contributions are accrued to its participating partner institutions below.

Creative Commons License

Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Return to institution outputs

Except where otherwise noted © 2019 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER